Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol

User: Guest

Title:: Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
Document type:: Zeitschriftenaufsatz
Author(s):: Ziegler, Anette-Gabriele; Achenbach, Peter; Berner, Reinhard; Casteels, Kristina; Danne, Thomas; Gündert, Melanie; Hasford, Joerg; Hoffmann, Verena Sophia; Kordonouri, Olga; Lange, Karin; Elding Larsson, Helena; Lundgren, Markus; Snape, Matthew D; Szypowska, Agnieszka; Todd, John A; Bonifacio, Ezio
Journal title:: BMJ Open
Year:: 2019
Journal volume:: 9
Journal issue:: 6
Pages contribution:: e028578
Fulltext / DOI:: doi:10.1136/bmjopen-2018-028578
Publisher:: BMJ
E-ISSN:: 2044-60552044-6055
Date of publication:: 01.06.2019
BibTeX

Occurrences: